All articles tagged with #nb181
A new COVID-19 variant, NB.1.8.1, is spreading globally but poses a low risk to public health, with no evidence of increased severity or impact on vaccine effectiveness, though it may exhibit some immune escape properties, according to the WHO.
A new COVID-19 variant, NB.1.8.1, is spreading in the U.S., accounting for 37% of cases, with symptoms including a severe sore throat called 'razor blade throat.' It may spread faster and evade immunity better than previous strains, though vaccines remain effective. Changes in U.S. vaccination policy could limit access for some groups.
A new covid-19 variant, NB.1.8.1, is rapidly spreading in the U.S., causing about 37% of cases and potentially leading to a summer surge, though it currently doesn't cause more severe illness and vaccines remain effective.
Recent reports suggest a severe sore throat described as 'razor blade throat' may be associated with the emerging NB.1.8.1 'Nimbus' COVID-19 variant, which is spreading rapidly and could indicate a potential surge. However, this symptom alone is not definitive for COVID-19, and proper testing and precautions are advised.
The epidemiological update reports a rise in SARS-CoV-2 infections in some Asian countries linked to the NB.1.8.1 variant, which is currently under monitoring by WHO and ECDC. In the EU/EEA, infection levels remain low with no significant impact on healthcare, but a potential increase in cases and hospitalizations is expected due to waning immunity and suboptimal vaccination coverage among older adults. Continued surveillance, vaccination, and public health measures are recommended to mitigate future waves.
A new Covid variant, NB.1.8.1, has emerged, spreading across several countries including Ireland, the UK, and popular holiday destinations, with symptoms more related to the digestive system such as diarrhea, nausea, and constipation, alongside traditional symptoms like sore throat and fatigue. The variant appears to spread more easily and may partially evade immunity, but is not yet linked to increased severity of illness.
A new COVID variant, NB.1.8.1, has emerged with mutations that may increase transmissibility and evade some immune defenses, but currently shows similar symptoms to other variants and no evidence of increased severity. It is spreading from China to the US, with ongoing monitoring by health authorities, and vaccines are expected to remain effective against severe illness.
A new COVID-19 variant, NB.1.8.1, part of the Omicron family, is spreading globally and is under monitoring by WHO. While currently considered low risk and not more severe, it may be more transmissible and could impact vaccinated and immunocompromised individuals. Experts emphasize the importance of vaccines and caution about increased indoor gatherings in the fall, but summer outdoor activities are less likely to be affected.
A new COVID variant, NB.1.8.1, has emerged with mutations that may increase transmissibility and immune evasion, but currently shows similar symptoms to other variants and no evidence of increased severity. It is spreading from China to the US, with some reports of a painful sore throat, but vaccines are expected to remain effective against severe illness. Monitoring continues as the variant's prevalence increases.
The World Health Organization warns about a new Covid-19 variant, NB.1.8.1, which is more transmissible but not more severe, with common symptoms like cough and nasal congestion, and a unique ability to evade immune defenses.
A new COVID-19 variant called NB.1.8.1 is circulating in parts of the world, leading to a rise in cases, particularly in the eastern Mediterranean, Southeast Asia, and the western Pacific. The WHO monitors this variant, which currently poses a low global health risk, and existing vaccines are expected to remain effective. Meanwhile, the U.S. has changed its vaccination recommendations for healthy children and pregnant women, sparking debate among health experts.
A new COVID-19 variant, NB.1.8.1, has been detected in Washington state, identified through airport surveillance. Although cases of this variant are rising globally, health officials consider it low risk to the public, with vaccines still effective against severe illness. The variant's presence in Washington is currently isolated, and there is no evidence it causes more severe disease.
A new COVID-19 strain, NB.1.8.1, has been detected in New York and other parts of the US, but it is currently rare and not considered a major public health threat. The strain appears to be more transmissible but does not cause more severe disease and is recognized by existing antibodies. Meanwhile, COVID-19 continues to circulate, and vaccine access may become more restricted for certain groups due to recent policy changes.
A new Covid-19 variant, NB.1.8.1, has been detected in Washington state, but health officials are not overly concerned as it does not appear to cause more severe illness and current vaccines are expected to remain effective. The variant was identified through CDC surveillance at Seattle-Tacoma International Airport, and its global prevalence has led the WHO to monitor it. Meanwhile, U.S. vaccination guidelines have shifted, with some restrictions on vaccine recommendations for children and pregnant women, sparking criticism.
A new highly transmissible COVID subvariant, NB.1.8.1, is spreading globally and detected in California, raising concerns about a potential summer wave. Meanwhile, the Trump administration has reversed federal recommendations for COVID vaccination in healthy children and pregnant women, citing a lack of benefit and aiming to generate more evidence. Experts warn that this could reduce vaccine access and increase health risks, especially for vulnerable populations, amid ongoing COVID transmission and hospitalizations.